These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7796591)

  • 1. Effects of mifepristone and progesterone on collagen synthesis in the human uterine cervix.
    Bokström H; Norström A
    Contraception; 1995 Apr; 51(4):249-54. PubMed ID: 7796591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical smooth muscle contractile activity after treatment with mifepristone and progesterone.
    Bokström H; Norström A; Rdestad A
    Contraception; 1994 Feb; 49(2):115-23. PubMed ID: 8143451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
    Gupta JK; Johnson N
    Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of progesterone and its antagonist mifepristone (RU 486) on collagen content in uterine cervix in pregnant rats.
    Bieńkiewicz A
    Endocr Res; 1995 Aug; 21(3):615-22. PubMed ID: 7588430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study.
    Rådestad A; Bygdeman M
    Contraception; 1992 Mar; 45(3):221-7. PubMed ID: 1511608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study.
    Rådestad A; Thyberg J; Christensen NJ
    Hum Reprod; 1993 Jul; 8(7):1136-42. PubMed ID: 8408500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of 12-hydroxyeicosatetraenoic acid in early pregnant uterine cervix--lack of correlation to mifepristone-induced cervical ripening. A double-blind randomized biomechanical and biochemical study.
    Heidvall K; Radestad A; Christensen NJ; Lindgren JA
    Prostaglandins; 1992 May; 43(5):473-82. PubMed ID: 1584996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
    Urquhart DR; Templeton AA
    Contraception; 1990 Aug; 42(2):191-9. PubMed ID: 2085969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
    Gupta JK; Johnson N
    Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized, biomechanical and biochemical study.
    Rådestad A; Bygdeman M; Green K
    Contraception; 1990 Mar; 41(3):283-92. PubMed ID: 2182288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical mucus concentration of prostaglandins E2 and F2 alpha after pretreatment with mifepristone in the first trimester of pregnancy.
    Bokström H; Norström A; Wiqvist N
    Prostaglandins; 1995 Jan; 49(1):41-8. PubMed ID: 7792390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.
    Bygdeman M; Gemzell K; Gottlieb C; Swahn ML
    Ann N Y Acad Sci; 1991; 626():561-7. PubMed ID: 2058973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
    Rådestad A; Christensen NJ; Strömberg L
    Contraception; 1988 Sep; 38(3):301-12. PubMed ID: 3168450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery.
    Chwalisz K
    Hum Reprod; 1994 Jun; 9 Suppl 1():131-61. PubMed ID: 7962460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of steroid hormones on the incorporation of amino acids in uterine and cervical tissue of pregnant women.
    Wiqvist I; Linde A
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):537-43. PubMed ID: 3630544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.